Therapeutic Area | MeSH |
---|---|
infections | D007239 |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
BENZNIDAZOLE | CHEMO Research | N-209570 RX | 2017-08-29 | 2 products, RLD, RS |
Brand Name | Status | Last Update |
---|---|---|
benznidazole | New Drug Application | 2025-03-05 |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
chagas disease | EFO_0008559 | D014355 | B57 |
bacterial infections | — | D001424 | A49 |
protozoan infections | — | D011528 | B50-B64 |
Expiration | Code | ||
---|---|---|---|
BENZNIDAZOLE, BENZNIDAZOLE, CHEMO RESEARCH SL | |||
2024-08-29 | ODE-154 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Chagas disease | D014355 | EFO_0008559 | B57 | — | — | 1 | — | — | 1 |
Drug common name | Benznidazole |
INN | benznidazole |
Description | Benznidazole is a monocarboxylic acid amide obtained by formal condensation of the carboxy group of (2-nitroimidazol-1-yl)acetic acid with the aromatic amino group of benzylamine. Used for treatment of Chagas disease. It has a role as an antiprotozoal drug. It is a member of imidazoles, a C-nitro compound and a monocarboxylic acid amide. |
Classification | Small molecule |
Drug class | antiprotozoal substances (metronidazole type) |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | O=C(Cn1ccnc1[N+](=O)[O-])NCc1ccccc1 |
PDB | — |
CAS-ID | 22994-85-0 |
RxCUI | — |
ChEMBL ID | CHEMBL110 |
ChEBI ID | — |
PubChem CID | 31593 |
DrugBank | DB11989 |
UNII ID | YC42NRJ1ZD (ChemIDplus, GSRS) |